期刊文献+

溃疡性结肠炎患者血清NGAL检测及意义 被引量:4

Clinical Significance of Serum Neutrophil Gelatinase-associated Lipocalin in Patients with Ulcerative Colitis
下载PDF
导出
摘要 目的探讨溃疡性结肠炎(UC)患者血液中NGAL的含量和意义。方法使用胶乳增强免疫比浊法检测89例UC患者血清中NGAL含量并与对照组比较。分析NGAL水平与UC患者WBC数量、PLT数量、CRP和Hgb、HCT、ESR、年龄、疾病活动程度(DAI)关系。结果 UC患者血清中NGAL水平显著高于健康对照组,中位数分别为112ng/m L和48.2ng/m L,差异有统计学意义(P<0.0001)。血清NGAL水平在轻度和中、重度UC患者血清NGAL中位数分别为78.2ng/m L和67.2ng/m L,差异有统计学意义(t=3.981,P=0.006)。UC患者血清NGAL水平与WBC数量、PLT数量、CRP和Hgb、HCT、ESR、年龄无关(P>0.05),与疾病活动程度(DAI)轻度相关(r=0.525,P<0.0001)。结论溃疡性结肠炎患者血清NGAL水平升高,升高水平与疾病活动程度有关,但是其在疾病中的作用尚需进一步研究。 Objective To explore the clinical significance of serum neutrophil gelatinase-associated lipocalin( NGAL) in patients with ulcerative colitis( UC). Methods The serum NGAL in 89 patients with UC and healthy controls were measured by using latex-enhanced immunoturbidimetric assay. The correlation between serum NGAL and blood WBC counts,PLT counts,CRP,Hgb,HCT,ESR,age,disease activity index( DAI)were analyzed. Results The serum NGAL levels in UC patients were markedly higher than that of the controls( P 〈 0. 0001). The serum NGAL levels in mild UC group were obviously lower than that in moderate-severe UC group( 78. 2 vs 67. 2ng / m L,P = 0. 006). There was no correlation between serum NGAL in UC patients and WBC counts,PLT counts,CRP,Hgb,HCT and ESR,age( P 〉 0. 05). The serum NGAL levels in UC patients was mildly positively correlated with disease activity index( r = 0. 525,P 〈 0. 0001). Conclusion The serum NGAL level in patients with UC is elevated and related with DAI,but its role in patients with UC needs to be further studied.
出处 《标记免疫分析与临床》 CAS 2015年第2期113-115,共3页 Labeled Immunoassays and Clinical Medicine
关键词 溃疡性结肠炎 中性粒细胞明胶酶相关脂质蛋白 生物标志物 疾病活动程度 Ulcerative colitis Neutrophil gelatinase-associated lipocalin Biomarker Disease activity index
  • 相关文献

参考文献13

  • 1Lippi G, Meschi T, Nouvenne A, et al. Neutrophile gelatinase- associated lipocalin in cancer. Adv Clin Chem, 2014,64 : 179-219.
  • 2Nielsen O H, Gionchetti P, Ainsworth M, et al. Rectal dialysate and fecal concentrations of neutrophil gelatinase- associated lipocalin, interleukin-8, and tumor necrosis factor-alpha in ulcerative colitis. Am J Gastroenterol, 1999,94 ( 10 ) :2923-2928.
  • 3中国炎症性肠病诊断治疗规范的共识意见[J].中华内科杂志,2008,47(1):73-79. 被引量:383
  • 4Lindberg S, Jensen J S, Mogelvang R, et al. Plasma neutrophil gelatinase- associated lipocalinin in the general population : association with inflammation and prognosis. Arterioscler Thromb Vasc Biol, 2014,34(9) :2135-2142.
  • 5Bao G, Clifton M, Hoette TM, et al. Iron traffics in circulation bound to a siderocalin (Ngal) - catechol complex. Nat Chem Biol, 2010,6(8) :602-609.
  • 6Chakraborty S, Kaur S, Guha S, et al. The multifaceted roles of neutrophil gelatinase associated lipocalin ( NGAL ) in inflammation and cancer. Biochim Biophys Acta, 2012,1826(1) :129-169.
  • 7Fischbach M A, Lin H, Liu D R, et al. How pathogenic bacteria evade mammalian sabotage in the battle for iron. Nat Chem Biol, 2006, 2(3) :132-138.
  • 8Yesil A, Gonen C, Senates E, et al. Relationship between neutrophil gelatinase-associated lipocalin (NGAL) levels and inflammatory bowel disease type and activity. DigDis Sci, 2013,58 (9) :2587-2593.
  • 9Oikonomou K A, Kapsoritakis A N, Theodoridau C, et al. Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity. J Gastroenterol, 2012,47 (5) :519-530.
  • 10de Bruyn M, Arijs I, Wollants W J, et al. Neutrophil gelatinase B- associated lipocalin and matrix metalloproteinase-9 complex as a surrogate serum marker of mucosal healing in ulcerative colitis. Inilamm Bowel Dis, 2014,20(7) :1198-1207.

二级参考文献18

  • 1潘国宗 刘彤华 见:潘国宗 曹世植9. 主编.溃疡性结肠炎[A].见:潘国宗,曹世植9.,主编.现代胃肠病学.第Ⅰ版[C].北京:科学出版社,1994.1246-1247.
  • 2潘国宗 刘彤华.Crohn病[A].见:潘国宗 曹世植 主编.现代胃肠病学[C].北京:科学出版社,1994.1154.
  • 3樋渡信夫 渡边浩光 前川浩树 等.溃疡性结肠炎的诊断标准与诊断进展[J].炎症性肠疾患胃与肠,1997,32(3):271-278.
  • 4八尾恒良.Crohn病的诊断标准与诊断进展[J].炎症性肠病疾患胃与肠,1997,32(3):317-326.
  • 5胡品津.炎症性肠病.见:叶任高,陆再英主编.内科学.第6版.北京:人民卫生出版社,2005.406-416.
  • 6欧阳钦.炎症性肠病的诊治进展.见:孟宪镛主编.实用消化病诊疗学.第2版.上海:世界图书出版社,2006.362-84.
  • 7Ouyang Q, Tandon R, Goh KL, et al. The emergence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastroenterol, 2005,21:408-413.
  • 8Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease : controversies, consensus, and implications. Gut, 2006, 55 : 749-753.
  • 9Kornbluth A, Sachar D. Ulcerative colitis practice guidelines in adults (update). Am J Gastroenterol, 2004,99 : 1371-1385.
  • 10Hanauer SB, Sandbom W, Practice Parameters Committee of the American College of Gastroenterology. Management of Crohn's disease in adults. Am J Gastroenterol, 2001,96: 635-643.

共引文献382

同被引文献30

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部